Abstract:The glutamate transporter gene SLC1A1 has been shown to have an association with obsessive-compulsive disorder (OCD), and serotonin reuptake inhibitor (SRI) treatment response. One polymorphism (rs3056) in SLC1A1 has been associated with altered brain volumes in OCD. We investigated the association of this polymorphism with OCD and its relationship with various clinical parameters, including age of onset, disease severity, insight, factor analyzed symptom dimensions of OCD, and SRI treatment response. Three hundred seventy seven OCD patients (DSM–IV) aged between 18 to 60 years were recruited from a specialty OCD clinic. To study the association with SRI treatment response, we analyzed full responders (≥35% reduction in the Yale Brown Obsessive Compulsive Scale [YBOCS] and the Clinical Global Impression–Improvement [CGI-I] score of 1 or 2) to any SRI (n = 187) and nonresponders (<25% reduction in the YBOCS and the CGI-I score >4) to adequate trials of at least two SRIs for a duration of 12 weeks (n = 91). Healthy controls (n = 333) were recruited and evaluated using the Mini-International Neuropsychiatric Interview–Plus (MINI-Plus). All subjects were from southern India, and were genotyped for the SLC1A1 polymorphism (rs3056). Genotype frequencies did not deviate significantly from the Hardy–Weinberg equilibrium. Case–control association analysis revealed that the "GG" genotype was significantly more frequent in OCD cases than the controls (p = .04). No association was found with the age of onset, symptom severity, insight, and symptom dimensions. No significant association was found between genotype/allele frequencies with treatment response. To conclude, although there was a significant association between the SLC1A1 rs3056 polymorphism and OCD, there were no significant associations with other clinical parameters or treatment response. (PsycInfo Database Record (c) 2020 APA, all rights reserved)

Association of SLC1A1 gene polymorphism with obsessive compulsive disorder in a sample from southern India.

Association of rs11081062 polymorphism of DLGAP1 gene and levels of SLC1A1 protein with obsessive-compulsive disorder

A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder

Association Between SLC1A1 Gene and Early-Onset OCD in the Han Chinese Population: A Case–Control Study

2653 – Influence of polymorphisms in genes SLC1A1, GRIN2B and GRIK2 on clozapine-induced obsessive-compulsive symptoms

[Molecular Pharmacogenetic Studies of Drug Responses to Obsessive-Compulsive Disorder and Six Functional Genes].

DRD4 gene and obsessive compulsive disorder: Do symptom dimensions have specific genetic correlates?

Population genetic variation of SLC6A4 gene, associated with neurophysiological development

Association Analysis of Serotonin 2A Receptor Gene Polymorphism and Obsessive-Compulsive Disorder

A Serotonin Transporter Gene (SLC6A4) Polymorphism Is Associated with Reduced Risk of Irritable Bowel Syndrome in American and Asian Population: A Meta-Analysis

Influence of Polymorphisms in Genes SLC1A1, GRIN2B, and GRIK2 on Clozapine-Induced Obsessive–compulsive Symptoms

Peripheral SLC6A4 Gene Expression in Obsessive-Compulsive Disorder in the Han Chinese Population.

Association of the Candidate Gene SLC1A1 and Obsessive–compulsive Disorder in Han ChinesePopulation

Serotonin transporter gene (SLC6A4) polymorphisms are associated with response to fluoxetine in south Indian major depressive disorder patients

Association Between Obsessive-Compulsive Disorder and Polymorphism of Serotonin Transporter Gene

Relation between executive functions and polymorphisms in COMT, MAO-A, HTTLPR, SLC1A1 and HT2A in a sample of children with Obsessive Compulsive Disorder

Clinical Characteristics and Association Analysis of Serotonin 2A Receptor Gene T102C Polymorphism with Obsessive Compulsive Symptoms in Three Different Conditions

Sex Determines Which Section Of The Slc6a4 Gene Is Linked To Obsessive-Compulsive Symptoms In Normal Chinese College Students

BDNF association study with obsessive-compulsive disorder, its clinical characteristics, and response to fluvoxamine-treatment in Iranian patients

Neurotransmitter system gene variants as biomarkers for the therapeutic efficacy of rTMS and SSRIs in obsessive-compulsive disorder

Association Study Between IL-1β−511 C/T Polymorphism and Obsessive-Compulsive Disorder (OCD) in Chinese Han Population